Coartem

Coartem Dispersible a unique, child-friendly, sweet-tasting, dispersible formulation of the parent drug Coartem®.

unknown title 2009

It bought a new Chinese patent on a mix of artemether, an artemisinin derivative, and lumefantrine, another Chinese drug, and took out Western patents, planning to sell it under the name Riamet at high prices to tourists and militaries; in 2001, it agreed to sell it nearly at cost to the WHO under the name Coartem.

The Seattle Times 2012

The new pill, which has received regulatory approval in Switzerland and in several African countries, is based on an existing Novartis malaria treatment called Coartem that is designed for adults and is often crushed to better suit children.

New Child-Friendly Malaria Drug Presents Distribution Challenge 2009

Novartis, which makes the expensive formulation of the combination drug (theirs is called Coartem), announced a major charity program in Tanzania this morning.

Merrill Goozner: Where's Wolfowitz On World Malaria Day? 2008

UNIDENTIFIED FEMALE: The one part of the Coartem, which is the artemether part, is derived from a plant in China that's been used for over 1,700 years, traditionally for the treatment of fever, and then for the treatment of malaria as well.

CNN Transcript Feb 16, 2002 2002

In addition, over 400 million treatments of Novartis' artemisinin combination therapy (ACT), Coartem, have been delivered over the last decade, while 229 million ACT treatments were procured worldwide in 2010 thanks to other companies and product development partnerships (PDPs).

Jeffrey L. Sturchio: Malaria: Solid Success but No Time for Complacence Jeffrey L. Sturchio 2011

In addition, over 400 million treatments of Novartis' artemisinin combination therapy (ACT), Coartem, have been delivered over the last decade, while 229 million ACT treatments were procured worldwide in 2010 thanks to other companies and product development partnerships (PDPs).

Jeffrey L. Sturchio: Malaria: Solid Success but No Time for Complacence Jeffrey L. Sturchio 2011

For example, Vasella recognizes that not all patients have the wherewithal to pay, so Novartis has had a big focus on malaria in Africa, where they are giving away a drug called Coartem.

Bill George On The Ill Health Of Health Care Ethisphere staff 2010

In 2001, Novartis agreed to sell its malaria medicine Coartem 'at cost' for close to $2.50.

Tido von Schoen-Angerer: A Tale of Two Vaccines -- Why Price Discounts for Developing Countries Show Limits Tido von Schoen-Angerer 2010

Distribution of Coartem and other drugs is largely done through an international nonprofit fund set up for the purpose of paying for medicines in developing countries.

New Child-Friendly Malaria Drug Presents Distribution Challenge 2009